S Navardi
Overview
Explore the profile of S Navardi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
3
Citations
25
Followers
0
Related Specialty
Related Specialty
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kasbi N, Ghadiri F, Sahraian M, Nahayati M, Moghadasi A, Langroodi H, et al.
Acta Neurol Belg
. 2023 Sep;
124(1):205-212.
PMID: 37715074
Background: Ocrelizumab is a humanized antiCD20, thought to be a highly effective disease-modifying therapy (DMT). Its most frequent adverse effects are infusion-related reactions (IRRs). To reduce these reactions, the first...
2.
Navardi S, Sahraian M, Moghadasi A
Rev Neurol (Paris)
. 2019 Nov;
176(4):289-290.
PMID: 31668286
No abstract available.
3.
Rahmanzadeh R, Weber M, Bruck W, Navardi S, Sahraian M
Acta Neurol Scand
. 2018 Mar;
137(6):544-556.
PMID: 29512131
For decades, B cells were ignored in multiple sclerosis (MS) pathogenesis, and the disease was always regarded as a T cell-mediated disorder. Recent evidence shows that there is an antigen-driven...